Clinical Trials · NCT07754461
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 600
- Start date
- Aug 2026
- Locations
- 120 sites, 6 countries
- Primary endpoint
- Absolute change in glycosylated haemoglobin A1c (HbA1c) (%) from baseline to Week 41